Phibro Animal Health's EPS (Basic) for the
three
months ended in Mar. 2024 was €0.19.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 was €0.30.
During the past 12 months, Phibro Animal Health's average EPS without NRIGrowth Rate was -14.30% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was 0.20% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was -9.00% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was -0.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.
During the past 13 years, Phibro Animal Health's highest 3-Year average EPS without NRI Growth Rate was 73.40% per year. The lowest was -20.20% per year. And the median was -2.60% per year.
Phibro Animal Health EPS (Diluted) Historical Data
The historical data trend for Phibro Animal Health's EPS (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Phibro Animal Health's EPS (Diluted)
For the Drug Manufacturers - Specialty & Generic subindustry, Phibro Animal Health's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Phibro Animal Health's PE Ratio Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Phibro Animal Health's PE Ratio distribution charts can be found below:
* The bar in red indicates where Phibro Animal Health's PE Ratio falls into.
Phibro Animal Health EPS (Diluted) Calculation
EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.
Phibro Animal Health's Diluted EPS for the fiscal year that ended in Jun. 2023 is calculated as
EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.30
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Phibro Animal Health (FRA:PB8) EPS (Diluted) Explanation
EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Phibro Animal Health EPS (Diluted) Related Terms
Thank you for viewing the detailed overview of Phibro Animal Health's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.
Phibro Animal Health (FRA:PB8) Business Description
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:PB8 has been successfully added to your 